Anthony S. Fiorino - Net Worth and Insider Trading

Anthony S. Fiorino Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anthony S. Fiorino owns 3 companies in total, including Immune Pharmaceuticals Inc (IMNPQ) , Navidea Biopharmaceuticals Inc (NAVB) , and Brainstorm Cell Therapeutics Inc (BCLI) .

Click here to see the complete history of Anthony S. Fiorino’s form 4 insider trades.

Insider Ownership Summary of Anthony S. Fiorino

Ticker	Comapny	Transaction Date	Type of Owner
IMNPQ	Immune Pharmaceuticals Inc	2020-02-03	director
NAVB	Navidea Biopharmaceuticals Inc	2016-03-23	director
BCLI	Brainstorm Cell Therapeutics Inc	2014-06-09	Chief Executive Officer

Anthony S. Fiorino Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Anthony S. Fiorino Ownership Network

Ownership Network List of Anthony S. Fiorino

No Data

Ownership Network Relation of Anthony S. Fiorino

Anthony S. Fiorino Owned Company Details

What does Immune Pharmaceuticals Inc do?

Who are the key executives at Immune Pharmaceuticals Inc?

Anthony S. Fiorino is the director of Immune Pharmaceuticals Inc. Other key executives at Immune Pharmaceuticals Inc include director & Interim CEO Elliot M Maza , See Remarks John Militello , and director & CFO and Senior VP Robert W. Cook .

Immune Pharmaceuticals Inc (IMNPQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immune Pharmaceuticals Inc (IMNPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immune Pharmaceuticals Inc (IMNPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immune Pharmaceuticals Inc (IMNPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immune Pharmaceuticals Inc Insider Transactions

No Available Data

What does Navidea Biopharmaceuticals Inc do?

Who are the key executives at Navidea Biopharmaceuticals Inc?

Anthony S. Fiorino is the director of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .

Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Navidea Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Brainstorm Cell Therapeutics Inc do?

Who are the key executives at Brainstorm Cell Therapeutics Inc?

Anthony S. Fiorino is the Chief Executive Officer of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .

Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary

Over the past 18 months, Anthony S. Fiorino made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 566,372 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .

In summary, during the past 3 months, insiders sold 63,000 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 0 shares, with a net sale of 63,000 shares. During the past 18 months, 63,000 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 577,872 shares were bought by its insiders, resulting in a net purchase of 514,872 shares.

Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Brainstorm Cell Therapeutics Inc Insider Transactions

No Available Data

Anthony S. Fiorino Mailing Address

Above is the net worth, insider trading, and ownership report for Anthony S. Fiorino. You might contact Anthony S. Fiorino via mailing address: C/o Brainstorm Cell Therapeutics, Inc., 605 Third Avenue, 34th Floor, New York Ny 10158.

Discussions on Anthony S. Fiorino

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.